I found a very positive article regarding ATH434 this morning - it is dated 5th August.
Some observations at the end of the article....
"The news about ATH434 is promising. The product is orally administered, safe, promising and first of a new generation of small molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration.
If approved, ATH434 would represent a great moment in the history for the treatment of neurodegenerative diseases."
https://www.prohostbiotech.com/alterity-therapeutics-treating-neurodegenerative-diseases/
I found a very positive article regarding ATH434 this morning -...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.937K | 645.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 77 | 96988980 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 655773 | 2 |
View Market Depth
| Last trade - 10.00am 15/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |